Rohtak News Magazine

Image-Guided Biopsy Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence

 Breaking News
  • No posts were found

Image-Guided Biopsy Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence

November 03
16:20 2022
Image-Guided Biopsy Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence
DataM Intelligence
Global Image-Guided Biopsy Market is projected to reach a high CAGR of 5.49% during the forecast period 2022-2029.

Market Overview:

Image-Guided Biopsy Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.49 % during the forecast period (2022-2029).

Imaging technology are utilized in photo-guided biopsy to peer in the body. By positioning the needle in the right place in the course of the biopsy, the medical professional can fast get a pattern of the elaborate cell. It is diagnosed as one of the satisfactory series strategies as it reasons little harm.

This approach is often carried out in one of the  locations, inclusive of the Interventional Radiology (IR) suite using ultrasound or fluoroscopy (X-rays) or the CT room the use of a CT scanner, as pics are had to guide the location of the needle during a biopsy.

To Download free sample @ Click Here

Market Dynamics:

Innovation inside the Diagnostic Outcome of Image-Guided Percutaneous Core Needle Biopsy of Sclerotic Bone Lesions is anticipated to pressure market growth.

The diagnostic yield of photo-guided percutaneous CNB of sclerotic bone lesions has accuracy in estimating and differentiating benign from malignant lesions and suggests very good outcomes. Moreover, as compared to the manual approach, the battery-powered bone biopsy device had a extra pooled fraction of the diagnostic output.

For instance, severa investigations discovered that sclerotic bone lesions had decrease diagnostic yields than lytic bone lesions. Sclerotic lesions have extensively decreased tumor cellularity and reactive bone manufacturing. The manual drill mechanism is replaced with a battery-powered drill gadget to get around this limit. This technique is applied for the aspiration and biopsy of bone marrow before being used for the biopsy of sclerotic bone lesions.

The battery-powered drill device is found to have numerous advantages in those tests, including improved specimen size and first-rate and reduced method time, radiation dosage, and other elements. Therefore, considering those consequences, picture-guided percutaneous CNB of sclerotic bone lesions is a reliable diagnostic method with a high diagnostic yield, in particular while battery-powered bone biopsy system is employed. Thus, from the above statements, the marketplace is predicted to force in the forecast period.

Market Segmentation

By Technology

  • X- Ray
  • Ultrasound
  • Mammography
  • CT

By Process

  • Fine Needle
  • Core Needle
  • Vacuum- Assisted Biopsy
  • Others

By Indication

  • Cancer
  • Liver Disease
  • Kidney Disease
  • Infectious Diseases

By End-user

  • Hospitals*
  • Diagnostic Centers
  • Ambulatory Surgery Centers
  • Research Institutes

Competitive Landscape

Major key players in the image-guided biopsy market are Koninklijke Philips N.V, Siemens Healthcare GmbH, GE Healthcare, Brainlab, Medtronic, Olympus Corporation, Stryker, Hologic Inc.

Trending Topics

Endobronchial Ultrasound Biopsy Market

Intravascular Ultrasound Market

Aspiration and Biopsy Needles Market

Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/image-guided-biopsy-market

Related Articles